Veru Inc.
Most Recent Event
KOL Connect
May 8, 2025
Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru
Veru is a biopharmaceutical company focused on developing novel medicines for cardiometabolic and inflammatory diseases.
NASDAQ: VERU
About
Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic and inflammatory diseases. The Company’s drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin.
Join Us
Sign up for email alerts to stay up-to-date on the latest Virtual Investor events
By submitting this form, you are consenting to receive marketing emails from: Virtual Investor. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact